Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Surgical Oncology
|
August 2, 2022
Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis
Samer A Naffouje, Nicholas Manguso, Iman Imanirad, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
August 9, 2023
Return to intended oncologic therapy after colectomy for stage III colon adenocarcinoma: Does surgical approach matter?
David T Pointer, Seth I Felder, Benjamin D Powers, et al.
Journal of Surgical Oncology
|
December 10, 2024
Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis
Leah E Hendrick, Samer Naffouje, Iman Imanirad, et al.
Cancers
|
February 10, 2024
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer
Dae Won Kim, Young-Chul Kim, Bence P Kovari, et al.
Oncology
|
December 7, 2023
RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab
Ruoyu Miao, Dae Won Kim, James Yu, et al.
Leukemia Research
|
November 28, 2013
High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment
Christopher R Cogle, Michelle R Iannacone, Daohai Yu, et al.
Annals of Surgical Oncology
|
February 22, 2025
The Transcriptomic Landscapes of Appendiceal Primary and Metastatic Tumors are Distinct
Margaret A Park, Richard Jacobson, Maria Genilo-Delgado, et al.
British Journal of Cancer
|
April 8, 2021
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer
Dae Won Kim, Elaine Tan, Jun-Min Zhou, et al.
American Journal of Clinical Oncology
|
February 7, 2020
Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation
Marissa L Frazer, George Yang, Seth Felder, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2022
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
Richard D Kim, Bence P Kovari, Maria Martinez, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Surgical Oncology
|
August 2, 2022
Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis
Samer A Naffouje, Nicholas Manguso, Iman Imanirad, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
August 9, 2023
Return to intended oncologic therapy after colectomy for stage III colon adenocarcinoma: Does surgical approach matter?
David T Pointer, Seth I Felder, Benjamin D Powers, et al.
Journal of Surgical Oncology
|
December 10, 2024
Incomplete Resection Is Twice as Likely in Locally Advanced Mucinous Compared to Nonmucinous Rectal Adenocarcinoma: A National Propensity-Matched Analysis
Leah E Hendrick, Samer Naffouje, Iman Imanirad, et al.
Cancers
|
February 10, 2024
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer
Dae Won Kim, Young-Chul Kim, Bence P Kovari, et al.
Oncology
|
December 7, 2023
RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab
Ruoyu Miao, Dae Won Kim, James Yu, et al.
Leukemia Research
|
November 28, 2013
High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainment
Christopher R Cogle, Michelle R Iannacone, Daohai Yu, et al.
Annals of Surgical Oncology
|
February 22, 2025
The Transcriptomic Landscapes of Appendiceal Primary and Metastatic Tumors are Distinct
Margaret A Park, Richard Jacobson, Maria Genilo-Delgado, et al.
British Journal of Cancer
|
April 8, 2021
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer
Dae Won Kim, Elaine Tan, Jun-Min Zhou, et al.
American Journal of Clinical Oncology
|
February 7, 2020
Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation
Marissa L Frazer, George Yang, Seth Felder, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2022
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
Richard D Kim, Bence P Kovari, Maria Martinez, et al.
Page
of 4